STAT-Dx is an innovative molecular diagnostics (MDx) company specialized in the developing advanced molecular diagnostic systems aimed at supporting Timely and Efficient Patient Care, while Optimizing Laboratory and Hospital Processes & Operations. ISO 13485 accreditation and adherence to robust quality systems are the key element for the company when developing systems for critical applications. From initial specification definition, through development and manufacturing, STAT-Dx has proven quality disciplines that ensure the highest standards are kept throughout.
STAT-Dx operates advanced manufacturing facilities and world-class equipment to ensure that DiagCORE® solutions meet the highest standards of quality, precision, and performance. STAT-Dx’s capabilities are tailored to meet the growing demand of our customers.